Transfusion risks of yesterday and of today

Transfusion Clinique et Biologique

Volumn 10, Issue 1, 2003, Pages 1-5

  Allain, Jean Pierre ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

HCV; HIV; Screening; Transfusion; Transfusion risks

Indexed keywords

NUCLEIC ACID; VIRUS RNA;

ARTICLE; BLOOD TRANSFUSION; COST EFFECTIVENESS ANALYSIS; DEATH; ERROR; EUROPE; HAZARD; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; RISK ASSESSMENT; RISK FACTOR; SCREENING; SEROLOGY; UNITED STATES; VASCULARIZATION; VIRUS TRANSMISSION;

EID: 0037309376     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(02)00276-8     Document Type: Article

References (7)

1. Kleinman SH, Busch MP. The risk of transfusion-transmitted infection: direct estimation and mathematical modeling. Baillieres Best Pract Res Clin Haematol 2000;13:631-50.
2. Busch MP, Stramer SL. The efficiency of HIV p24 antigen screening of US blood donors: projections versus reality. Infusion Ther Transfusion Med 1998;25:194-7.
3. Kleinman S, Aubuchon JP, Marshall DA, Wong JB, Grima D, Weinstein MC. Cost-effectiveness of screening donated blood with NAT for HBV, HCV and HIV. Transfusion 2001;41(Suppl):1S [Abstract P1].
4. Allain JP. Will genome detection replace serology in blood screening for microbial agents? Baillieres Best Pract Res Clin Haematol 2000;13:615-29.
5. Stramer SL, Porter RA, Brodsky JP. Replacement of HIV-1 p24 antigen screening with HIV-1 RNA nucleic acid testing (NAT) for whole blood donations. Transfusion 1999;39(Suppl):2S [abstract].
6. Allain JP. Emerging viral infections relevant to transfusion medicine. Blood Rev 2000;14:173-81.
7. SHOT report 2000-2001. United Kingdom; 2002.